tm logo
Trademark Search
RECURSION IS INDUSTRIALIZING DRUG DISCOVERY

View On IC.GC.CA

RECURSION IS INDUSTRIALIZING DRUG DISCOVERY
REGISTERED

on 12 Jan 2024

Last Applicant/ Owned by

RECURSION PHARMACEUTICALS INC.

41 South Rio Grande StreetSalt Lake City, UT 84101

US

Serial Number

2060963 filed on 30th Oct 2020

Registration Number

TMA1217954 registered on 12th Jan 2024

Registration expiry Date

12th Jan 2034

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

RECURSION IS INDUSTRIALIZING DRUG DISCOVERY

Trademark usage description

computer software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious Read More

Classification Information

Class [009]
Computer software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases, to prescribe medical treatment for blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze patient medical information, and to develop pharmaceutical products and chemical compounds for diagnosing and treating blood disorders, rare genetic disorders, and infectious diseases

Classification kind code

12

Class [042]
Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract pharmaceutical research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services, namely, research and development of new pharmaceutical drugs; Drug use discovery services, namely, research and development of new pharmaceutical drugs; Scientific and technological research services namely, medical research laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; Software as a service (SaaS) featuring software to diagnose medical conditions, namely, blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases, to prescribe medical treatment for blood disorders, rare genetic disorders, oncological diseases and disorders, and infectious diseases and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze patient medical information, and to develop pharmaceutical products and chemical compounds for diagnosing and treating blood disorders, rare genetic disorders, and infectious diseases

Classification kind code

12

Mark Details

Serial Number

2060963

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 25th Oct 2023		Advertised
Submitted for opposition 27
on 29th Sep 2023		Approval Notice Sent
Submitted for opposition 26
on 29th Sep 2023		Approved
Submitted for opposition 67
on 07th Oct 2022		Agent Name Changed
Submitted for opposition 22
on 15th Sep 2022		Search Recorded
Submitted for opposition 20
on 15th Sep 2022		Examiner's First Report
Submitted for opposition 287
on 22nd Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 30th Oct 2020		Filed
Submitted for opposition 1
on 30th Oct 2020		Created
Submitted for opposition 31
on 30th Oct 2020		Formalized